ORGANICNANO INC — Department of Defense STTR Phase I: AF19C-T010

ORGANICNANO INC — STTR Phase I award from Department of Defense.

Amount
$25,000
Agency
Department of Defense · Air Force
Program / Phase
STTR · Phase I
Topic
AF19C-T010
Solicitation
19.C
NAICS
Place of performance
LA
Period
2019-12-12 → 2020-12-12

Description

The use of antibacterial 3D printed filament has promising potential applications for the development of medical devices designed to prevent bacterial adhesion and growth on postoperative prostheses, wound dressings, invasive implants, medical fittings and tubing, surgical equipment, etc. Our technology can produce biocompatible products tailored for almost any use in the body or applied as permanently implantable or bioabsorbable devices. It can provide custom formulations that are cost effective and contain an increased antibiotic loading capacity as compared to conventional compositions. It provides increased control over release kinetics of loaded drugs (10-100 hrs. plus). All medical facilities can use this technology in the treatment of chronic wounds, against intra-hospital infections, and various microbial infections thus aiding in the control, prevention and spread of infectious disease for all military personnel, their families and the public. Furthermore, the same polymer/mHNT composites can also be used to generate nano- and microfibers using electrospinning and using the blow spinning spray technique to produce antimicrobial mHNTs coatings, laminates, stent coatings, textiles, and other medical device applications. These products will be stronger, safer, and more durable and significantly improve clinical outcomes and raise the level patient care.